Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YELL
3176
DELISTED
Yellow Corporation Common Stock
YELL
| $2.44M | ﹤0.01% |
431,451
-40,677
| -9% | -$236K |
|
3177
Ultrapar
UGP
$6.95B
| $2.43M | ﹤0.01% |
899,578
+202,834
| +29% | +$640K |
|
3178
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
| $2.43M | ﹤0.01% |
32,244
-730
| -2% | -$56.7K |
|
3179
Eterna Therapeutics
ERNA
$3.83M
| $2.43M | ﹤0.01% |
35
+4
| +13% | +$345K |
|
|
AY
3180
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.42M | ﹤0.01% |
70,253
+13,586
| +24% | +$515K |
|
3181
Stereotaxis
STXS
$126M
| $2.42M | ﹤0.01% |
450,209
-68,874
| -13% | -$519K |
|
|
VIRX
3182
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.42M | ﹤0.01% |
302,096
-11,254
| -4% | -$111K |
|
|
ATNX
3183
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.42M | ﹤0.01% |
40,195
-2,648
| -6% | -$193K |
|
3184
Vera Bradley
VRA
$97M
| $2.42M | ﹤0.01% |
257,077
-5,341
| -2% | -$58.5K |
|
3185
Angi Inc
ANGI
$229M
| $2.42M | ﹤0.01% |
19,577
-10,951
| -36% | -$1.26M |
|
3186
South Plains Financial
SPFI
$845M
| $2.41M | ﹤0.01% |
98,811
-534
| -0.5% | -$12.4K |
|
|
AXDX
3187
DELISTED
Accelerate Diagnostics
AXDX
| $2.4M | ﹤0.01% |
41,227
+3,618
| +10% | +$236K |
|
|
GTYH
3188
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $2.4M | ﹤0.01% |
319,309
-16,223
| -5% | -$116K |
|
3189
Vor Biopharma
VOR
$1.15B
| $2.4M | ﹤0.01% |
7,653
+2,104
| +38% | +$625K |
|
3190
YPF
YPF
$206B
| $2.4M | ﹤0.01% |
514,985
-300,824
| -37% | -$1.41M |
|
|
RXDX
3191
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.4M | ﹤0.01% |
101,026
-9,712
| -9% | -$229K |
|
3192
Intapp
INTA
$2.52B
| $2.38M | ﹤0.01% |
+92,558
| New | +$3.01M |
|
3193
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
| $2.38M | ﹤0.01% |
32,345
+3,690
| +13% | +$281K |
|
3194
The Honest Company
HNST
$402M
| $2.37M | ﹤0.01% |
228,562
-27,911
| -11% | -$341K |
|
|
ONCT
3195
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $2.37M | ﹤0.01% |
28,452
-1,030
| -3% | -$85.2K |
|
3196
FS Bancorp
FSBW
$319M
| $2.37M | ﹤0.01% |
68,539
-5,349
| -7% | -$184K |
|
3197
Bolt Biotherapeutics
BOLT
$7.67M
| $2.36M | ﹤0.01% |
9,339
+3,421
| +58% | +$967K |
|
3198
iPath Select MLP ETN
ATMP
$639M
| $2.36M | ﹤0.01% |
149,643
-16,998
| -10% | -$264K |
|
3199
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
| $2.36M | ﹤0.01% |
17,620
-6,312
| -26% | -$869K |
|
3200
SK Telecom
SKM
$12.1B
| $2.35M | ﹤0.01% |
47,458
-349,032
| -88% | -$16.9M |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.